Get the Stockscreener App
21.41
4.33%
-1.01
Caredx Inc stock is traded at $21.41, with a volume of 229.14K.
It is down -4.33% in the last 24 hours and up +21.87% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$22.42
Open:
$22.97
24h Volume:
229.14K
Relative Volume:
0.35
Market Cap:
$1.10B
Revenue:
$379.81M
Net Income/Loss:
$-21.35M
P/E Ratio:
-54.30
EPS:
-0.3943
Net Cash Flow:
$35.44M
1W Performance:
+33.64%
1M Performance:
+21.87%
6M Performance:
+48.85%
1Y Performance:
+21.74%
1-Day Range:
$21.38
$23.24
1-Week Range:
$15.80
$23.24
52-Week Range:
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
21.38 | 1.15B | 379.81M | -21.35M | 35.44M | -0.3943 |
TMO
Thermo Fisher Scientific Inc
|
527.33 | 191.76B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
196.22 | 137.14B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
591.91 | 45.27B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
120.91 | 33.42B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
327.43 | 31.32B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments By Investing.com - Investing.com Canada
CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors - GuruFocus
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments - Investing.com
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) CEO has 62,049 shares withheld to cover RSU tax bill - Stock Titan
CareDx Up 28%, on Track for Largest Percent Increase Since May 2024 -- Data Talk - Moomoo
CareDx Sharpens Focus On Core Testing Services - Benzinga
CareDx (NASDAQ:CDNA) Reaches New 1-Year HighHere's Why - MarketBeat
CareDx Sells Lab Products Business to EuroBio Scientific for $170 Million, Reports 48% Growth in Testing Services Revenue - Minichart
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday - Benzinga
CareDx Divests Lab Products to Refocus on Core Growth - TipRanks
CDNA Reports 17% Increase in Q1 Testing Service Volume - GuruFocus
CareDx (NASDAQ: CDNA) divests Lab Products business in $170M Eurobio deal - Stock Titan
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division - marketscreener.com
CareDx (CDNA) Soars After Divestiture Announcement and Strong Re - GuruFocus
CareDx (CDNA) Sells Lab Products Division for $170M - GuruFocus
CareDx to sell lab products unit for $170 million in cash - Investing.com India
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing - National Today
(CDNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Caredx announces agreement to divest lab products business to Eurobio Scientific for $170 million and announces first quarter preliminary financial results - marketscreener.com
CareDx (CDNA) Sees 20% Surge Following Q1 Pre-Announcement - GuruFocus
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results - Business Wire
CareDx and Omada Health Compared: Which Medical Stock Stands Out? - National Today
CareDx (CDNA) Q4 Earnings Miss Estimates - Eastern Progress
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks - Yahoo Finance
Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific - fenwick.com
Eurobio Scientific Société anonyme entered into a definitive agreement to acquire Lab Products Business of CareDx, Inc. for $170 million. - marketscreener.com
Press Release: CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - 富途牛牛
Aug PreEarnings: Whats the RSI of CareDx Inc stockMarket Trend Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Book value per share of CareDx, Inc. – DUS:1K9 - TradingView — Track All Markets
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
A Look at CareDx Inc (CDNA) After 3.8% Decline -- GF Value $18.92 vs Price $16.05 - GuruFocus
CareDx (NASDAQ:CDNA) Shares Down 7.9%What's Next? - MarketBeat
Aug Ideas: Is CareDx Inc stock a buy or sell2026 Earnings & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CareDx (NASDAQ:CDNA) Shares Pass Above 50-Day Moving AverageHere's Why - MarketBeat
345,308 Shares in CareDx, Inc. $CDNA Purchased by Aberdeen Group plc - MarketBeat
Can CareDx Inc stock outperform in a bear market2026 Technicals & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Geopolitics Watch: Can CareDx Inc stock outperform in a bear market2026 Retail & Weekly Top Gainers Alerts - baoquankhu1.vn
Aug Outlook: Is CareDx Inc gaining market share2026 Trade Ideas & High Conviction Buy Zone Picks - baoquankhu1.vn
CareDx (CDNA) counsel’s RSU vesting triggers 1,892-share tax withholding - Stock Titan
Buy Signal: Whats the RSI of CareDx Inc stockWeekly Profit Recap & Daily Price Action Insights - baoquankhu1.vn
Price-Driven Insight from (CDNA) for Rule-Based Strategy - Stock Traders Daily
CareDx (NASDAQ: CDNA) CEO has 35,037 shares withheld for taxes - Stock Titan
[Form 4] CareDx, Inc. Insider Trading Activity - Stock Titan
CareDx (NASDAQ: CDNA) CCO covers RSU taxes with 7,386 shares - Stock Titan
CareDx (CDNA) GC has 3,987 shares withheld for RSU taxes - Stock Titan
CareDx (CDNA) director receives automatic quarterly stock grant - Stock Titan
RSI Check: Can CareDx Inc keep up with sector leaders2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
CareDx, Inc. (CDNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Goldberg Michael | Director |
Mar 31 '26 |
Option Exercise |
3.35 |
26,500 |
88,648 |
183,961 |
| Novack Jeffrey Adam | Secretary and General Counsel |
Feb 03 '26 |
Sale |
20.56 |
4,441 |
91,286 |
125,364 |
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):